Go Pro

Traders Purchase High Volume of Call Options on Avantor (NYSE:AVTR)

Avantor logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Unusual options activity: Traders bought 25,142 call options on Avantor, a surge of 1,067% above the typical daily volume of 2,155 calls. This suggests a sharp rise in bullish speculation around the stock.
  • Shares fell on the day: Avantor stock was down 3.6% to $10.67 in midday trading, with volume below its average. The company still has a market cap of about $7.29 billion.
  • Analyst sentiment remains cautious: Wall Street’s consensus rating is currently “Reduce” with an average price target of $10.62. Recent firm updates were mostly neutral, with TD Cowen reaffirming a hold rating and Citigroup raising its target to $11.00.
  • Five stocks to consider instead of Avantor.

Avantor, Inc. (NYSE:AVTR - Get Free Report) saw some unusual options trading on Monday. Stock traders acquired 25,142 call options on the stock. This represents an increase of 1,067% compared to the typical daily volume of 2,155 call options.

Avantor Trading Down 3.6%

Avantor stock traded down $0.40 during mid-day trading on Monday, hitting $10.67. The stock had a trading volume of 5,932,218 shares, compared to its average volume of 10,431,110. The stock has a 50-day simple moving average of $9.40 and a two-hundred day simple moving average of $9.41. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $7.29 billion, a PE ratio of -13.23, a P/E/G ratio of 6.16 and a beta of 0.94. Avantor has a 12 month low of $7.26 and a 12 month high of $15.93.

Avantor (NYSE:AVTR - Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the prior year, the company posted $0.23 EPS. The company's revenue was up .0% compared to the same quarter last year. As a group, sell-side analysts forecast that Avantor will post 0.79 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AVTR. TD Cowen reaffirmed a "hold" rating on shares of Avantor in a report on Wednesday, July 15th. UBS Group set a $8.00 price target on Avantor in a report on Wednesday, June 24th. Citigroup raised their target price on Avantor from $9.00 to $11.00 and gave the company a "neutral" rating in a research note on Wednesday, July 8th. Evercore set a $10.50 price target on Avantor in a report on Monday, July 6th. Finally, Zacks Research raised shares of Avantor from a "strong sell" rating to a "hold" rating in a report on Thursday, April 30th. Two equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Reduce" and an average target price of $10.62.

Check Out Our Latest Stock Analysis on Avantor

Insider Activity at Avantor

In related news, Director Gregory T. Lucier bought 10,000 shares of the company's stock in a transaction dated Friday, May 8th. The stock was acquired at an average cost of $8.32 per share, with a total value of $83,200.00. Following the acquisition, the director owned 60,000 shares in the company, valued at approximately $499,200. This represents a 20.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Simon Dingemans purchased 25,000 shares of the stock in a transaction on Friday, May 1st. The stock was bought at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the transaction, the director directly owned 25,000 shares of the company's stock, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.28% of the company's stock.

Institutional Trading of Avantor

Institutional investors have recently bought and sold shares of the business. Handelsbanken Fonder AB lifted its stake in shares of Avantor by 41.2% in the 2nd quarter. Handelsbanken Fonder AB now owns 278,500 shares of the company's stock valued at $2,757,000 after purchasing an additional 81,200 shares during the period. Assenagon Asset Management S.A. increased its holdings in Avantor by 425.0% in the second quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company's stock valued at $5,513,000 after purchasing an additional 450,801 shares during the last quarter. GAMMA Investing LLC increased its holdings in Avantor by 93.3% in the second quarter. GAMMA Investing LLC now owns 46,592 shares of the company's stock valued at $461,000 after purchasing an additional 22,491 shares during the last quarter. Versant Capital Management Inc lifted its stake in Avantor by 372.1% in the second quarter. Versant Capital Management Inc now owns 9,073 shares of the company's stock valued at $90,000 after buying an additional 7,151 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in Avantor by 21.4% during the first quarter. Parallel Advisors LLC now owns 8,452 shares of the company's stock worth $66,000 after buying an additional 1,491 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

About Avantor

(Get Free Report)

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines